谷物活性剂调节肠道微生物群以改善与肥胖相关的代谢疾病:一篇评论
Youwei Zhao1, Jiawen Liu1, Shijie Sun1
1College of Food Science and Engineering, Jilin Agricultural University, Changchun, Jilin 130118, China; National Engineering Research Center for Wheat and Corn Deep Processing, Changchun, Jilin 130118, China.
Food research international (Ottawa, Ont.)
|December 10, 2024
概括
富含益生菌的全谷物可以改善肠道微生物群 (GM) 和宿主新陈代谢,有助于预防和管理肥胖. 本综述探讨了谷物生物活性化合物如何调节转基因来对抗代谢疾病.
科学领域:
- 营养科学 营养科学
- 微生物学 微生物学
- 代谢健康 代谢健康
背景情况:
- 全谷物饮食与改善代谢健康有关,包括肥胖,脂质不良,高血压和糖尿病.
- 谷物中的生物活性化合物可能充当益生菌,增强肠道完整性和宿主新陈代谢.
- 肠道微生物群 (GM) 在人类生理学中起着至关重要的作用,并且越来越多地与肥胖有关.
研究的目的:
- 审查转基因在肥胖中的生理作用.
- 讨论谷物衍生生物活性成分与转基因生物之间的相互作用.
- 总结关于不同谷物如何调节转基因对肥胖和代谢疾病改善的研究.
主要方法:
- 关于全谷物,肠道微生物群和代谢疾病的研究文献综述.
- 分析谷物生物活性化合物与转基因相互作用的机制.
- 通过转基因调节对各种谷物的对肥胖的影响研究结果的综合.
主要成果:
- 转基因是宿主新陈代谢和肥胖发展的组成部分.
- 来自全谷物的特定生物活性成分与转基因相互作用.
- 饮食中摄入多种全谷物显示出调节转基因对代谢益处的潜力.
结论:
- 全谷物通过调节肠道微生物群来调节肥胖.
- 谷物生物活性化合物为开发功能性食品提供了一个有希望的途径.
- 对谷物-转基因相互作用的进一步研究可以推进预防代谢疾病的战略.
相关概念视频
Regulation of Food Intake
187
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
187
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
159
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
159
Glucagon-like Receptor Agonists
298
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
298
Overview of Metabolism
29.5K
Living cells constantly carry out various chemical reactions which are necessary for their proper functioning. These reactions are interlinked to one another via multiple pathways. The collection of these chemical reactions is known as metabolism.
Plant Metabolism
Sunlight, the primary source of energy in plants, is first absorbed by the chlorophyll pigments present in their leaves. Plants then use this energy to carry out photosynthesis, where water is oxidized into oxygen and carbon dioxide...
Plant Metabolism
Sunlight, the primary source of energy in plants, is first absorbed by the chlorophyll pigments present in their leaves. Plants then use this energy to carry out photosynthesis, where water is oxidized into oxygen and carbon dioxide...
29.5K
Glucose Absorption Into the Small Intestine
31.3K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
31.3K
Irritable Bowel Syndrome I: Introduction
246
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
246


